Skip to main
MASI
MASI logo

Masimo (MASI) Stock Forecast & Price Target

Masimo (MASI) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 42%
Buy 37%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Masimo Corp reported strong growth in driver shipments, achieving 65,000, which surpassed expectations and marked an 8% quarter-over-quarter increase and an 11% year-over-year increase. The company also demonstrated improved profitability, with gross margins up 240 basis points and operating margins increasing by 570 basis points year-over-year, indicating operational efficiency and effective cost management. Looking ahead, Masimo reaffirmed its 2025 revenue guidance of 8-11% growth while raising its EPS guidance, reflecting confidence in continued strong performance driven by market share gains and new product launches.

Bears say

Masimo Corp's overall revenue growth has shown a decline, with the healthcare segment experiencing slower growth rates, down from 12% in the previous quarter to 9% in 4Q24, raising concerns about the company's market position in patient monitoring technologies. The bear case scenario suggests a potential further slowdown in revenue growth into mid-single digits due to decreased market share and disappointing product sales, leading to weaker-than-expected margins and earnings. Additionally, risks such as operational challenges, underperformance in new product lines, and adverse impacts from external factors like GLP-1 weight loss drugs further contribute to the negative outlook on the company’s financial stability.

Masimo (MASI) has been analyzed by 19 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 37% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Masimo (MASI) Forecast

Analysts have given Masimo (MASI) a Buy based on their latest research and market trends.

According to 19 analysts, Masimo (MASI) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $126.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $126.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Masimo (MASI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.